Muscle as a Metabolic and Endocrine Organ
For most of the twentieth century, skeletal muscle was understood primarily as a mechanical tissue — the machinery that moves bones through space. That understanding has been fundamentally revised over the past two decades. We now know that contracting skeletal muscle is one of the most important endocrine organs in the body, secreting hundreds of signaling proteins called myokines that regulate brain function, fat metabolism, immune response, bone density, cardiovascular health, and metabolic rate.
Irisin, one of the most studied myokines, is released during exercise and promotes the conversion of white adipose tissue to brown adipose tissue (fat browning), crosses the blood-brain barrier to stimulate BDNF (brain-derived neurotrophic factor) production, and has anti-diabetic effects through improving insulin sensitivity. IL-6, while notorious as a pro-inflammatory cytokine when chronically elevated in obesity and metabolic disease, has the opposite effect in the context of exercise-induced muscle contraction — acting as an anti-inflammatory myokine that stimulates glucagon-like peptide-1 (GLP-1) secretion, inhibits TNF-alpha, and activates lipolysis. BDNF itself is produced by working muscle and contributes to the well-documented cognitive benefits of exercise. The identification of over 650 distinct myokines by Pedersen and Febbraio (2012) in Nature Reviews Endocrinology revealed that muscle is perhaps the most important endocrine organ we have — and that its loss with age has systemic consequences far beyond strength and mobility.
Sarcopenia: The Silent Epidemic of Muscle Loss With Ageing
Adults begin losing skeletal muscle mass at a rate of 3 to 8 percent per decade after age 30. This rate accelerates to 10 to 15 percent per decade after age 60 in sedentary individuals. The condition — called sarcopenia — is characterized not just by mass loss but by declining muscle quality (increased intramuscular fat infiltration, reduced mitochondrial density, impaired neuromuscular connectivity) and loss of fast-twitch type II muscle fibers disproportionate to slow-twitch type I fibers.
Type II (fast-twitch) fibers are the most important for fall prevention — they are recruited for rapid, powerful contractions needed to catch yourself when you stumble. Their selective atrophy with ageing is one reason older adults have greater fall risk even when they can still walk reasonable distances. Falls in older adults cause approximately 300,000 hip fractures per year in the US, and hip fractures carry a one-year mortality rate of 20 to 30 percent in adults over 65 — primarily from immobility-related pneumonia, pulmonary embolism, and cardiovascular deconditioning.
The Mortality Evidence: Strength Predicts Survival
Multiple large prospective studies have established muscular strength as an independent predictor of all-cause mortality. Ruiz et al. (2008), publishing in the British Medical Journal, analyzed 8,762 men aged 20 to 80 followed over 18 years. After adjusting for age, cardiorespiratory fitness, body mass index, physical activity, and other confounders, the men in the highest muscular strength tertile had a 33 percent lower risk of death from any cause and a 40 percent lower risk of cancer mortality compared to men in the lowest tertile. Gale et al. (2007) in Age and Ageing demonstrated that grip strength at baseline predicted all-cause mortality over a 26-year follow-up in a population-based sample — a remarkably long follow-up period demonstrating the durability of the association.
Grip strength, while simple to measure, has repeatedly proven to be a powerful proxy for total body muscle strength and systemic health. A 2015 Lancet study by Leong et al. involving 142,861 adults across 17 countries found that grip strength was a stronger predictor of all-cause and cardiovascular mortality than systolic blood pressure. Every 5-kg decline in grip strength was associated with a 17 percent higher all-cause mortality risk and a 17 percent higher cardiovascular mortality risk.
Muscle as a Glucose Sink: The Metabolic Longevity Connection
Skeletal muscle accounts for approximately 70 to 80 percent of insulin-stimulated glucose uptake in the body. When insulin binds its receptor on muscle cell surfaces, it activates a signaling cascade that translocates GLUT4 glucose transporters to the cell membrane, dramatically increasing the rate of glucose transport into the cell. In individuals with insulin resistance, this cascade is impaired — GLUT4 translocation is blunted, blood glucose remains elevated, and the pancreas must secrete more insulin to achieve the same effect. Over years, this compensatory hyperinsulinemia and chronically elevated blood glucose drive type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, certain cancers, and accelerated ageing through advanced glycation end products.
Maintaining or increasing muscle mass is one of the most effective interventions for preventing insulin resistance. During muscular contraction, glucose uptake is dramatically increased through an entirely insulin-independent mechanism — AMPK activation causes GLUT4 translocation regardless of insulin levels. This is why exercise lowers blood glucose even in the absence of adequate insulin signaling — and why a single session of resistance training can improve insulin sensitivity for 24 to 48 hours post-exercise.
Training Variables for Longevity: A Practical Framework
Not all resistance training is equivalent for longevity. The research suggests a specific set of priorities for older adults and longevity-focused individuals:
| Variable | Longevity Recommendation | Rationale |
|---|---|---|
| Exercise Selection | Compound movements (squat, deadlift, press, row, carry) | Maximum muscle mass engaged per set, functional movement patterns |
| Frequency | 2–4 sessions/week (each muscle group 2×/wk minimum) | Sufficient stimulus for hypertrophy and strength adaptations |
| Volume | 10–20 sets per muscle group per week | Dose-response relationship with hypertrophy |
| Intensity | 60–85% 1-rep max, proximity to failure important | Recruits type II fast-twitch fibers selectively lost with age |
| Progressive Overload | Increase load, volume, or complexity over months | Essential to prevent accommodation and continued adaptation |
| Recovery | 48–72 hr between sessions per muscle group; 7–9 hr sleep | Adaptation occurs during recovery, not training |
Translating this framework into practice, the emphasis on compound movements and proximity to failure reflects the specific adaptations most protective against age-related decline: grip strength, lower-body power, and the preservation of type II fast-twitch fibre mass. The 10–20 weekly set recommendation is a working range, not a hard ceiling — research by Krieger (2010) and Schoenfeld (2017) shows dose-response up to ~20 sets, with diminishing returns beyond that for most trainees. For longevity-focused individuals over 50, the recovery row deserves particular attention: older adults show blunted muscle protein synthesis responses and require longer inter-session intervals to avoid cumulative fatigue, making the 48–72 hour guideline a true minimum rather than a conservative estimate.
The mTORC1 and IGF-1 Longevity Trade-Off
One important nuance in the strength training and longevity literature concerns the anabolic signaling pathway mTORC1 (mechanistic target of rapamycin complex 1). mTORC1 is the master regulator of protein synthesis and muscle hypertrophy — it is activated by mechanical loading, amino acids (especially leucine), and IGF-1, and its activation is precisely what drives muscle growth after resistance training. However, mTORC1 is also implicated in accelerated cellular ageing: constitutively elevated mTORC1 activity suppresses autophagy (the cellular self-cleaning process critical for longevity), and elevated IGF-1 in mid-life has been associated with increased cancer risk in some epidemiological studies.
This creates an apparent paradox: resistance training activates the very pathway (mTORC1) that many longevity researchers want to downregulate via caloric restriction or rapamycin. The resolution appears to be that the pulsatile nature of exercise-induced mTORC1 activation — brief, strong activation followed by return to baseline — is fundamentally different from constitutively elevated mTORC1 (as in obesity, chronic overfeeding, or excessive IGF-1). The temporal pattern matters enormously. Exercise transiently activates mTOR during and after training sessions, then allows recovery and autophagy to proceed during rest periods. This pattern appears to be net beneficial — building the functional muscle capacity that confers metabolic health while avoiding the chronic suppression of cellular maintenance that true mTOR overactivation causes.
Practical Recommendations by Age Group
Ages 20–40: Build your peak muscle mass and strength foundation. This is the time to invest in learning compound movement patterns with good form, developing strength across all movement planes, and establishing a training habit. The muscle mass you build now creates a buffer against age-related losses in subsequent decades.
Ages 40–60: Prioritize maintaining muscle quality and preventing the onset of insulin resistance. This is when the mTORC1 / IGF-1 trade-off discussion becomes most relevant — strategic periodization with adequate recovery, and ensuring protein intake (1.2–1.6 g/kg/day) supports muscle protein synthesis without excessive caloric surplus. Balance strength work with stability and mobility training to prevent injury.
Ages 60+: Shift primary goals toward functional strength, fall prevention, and preserving type II fiber recruitment. Higher protein intake (1.6–2.2 g/kg/day), possibly with leucine supplementation (2.5–3g per meal to overcome anabolic resistance), and training with moderate loads (60–70% 1RM) close to failure. Creatine monohydrate supplementation (3–5 g/day) has robust evidence for preserving muscle mass and cognitive function in older adults.